Evidence map›Paper›PMID 38268790›Full record

ArticleFrontiers in cellular and infection microbiology2023

Jiaze Dai, Wenying Luo, Fei Hu, Si Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. A novel approach to combatMicrobiology spectrum · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jiaze DaiMedical Laboratory Center, Affiliated Hospital of Guangdong Medical University, Zhan Jiang, Guang Dong, China.
Wenying LuoMedical Laboratory Center, Affiliated Hospital of Guangdong Medical University, Zhan Jiang, Guang Dong, China.
Fei HuMedical Laboratory Center, Affiliated Hospital of Guangdong Medical University, Zhan Jiang, Guang Dong, China.
Si LiGeneral Medicine, Clinical Medicine, Kangda College of Nanjing Medical University, LianYun Gang, Jiang Su, China.
Guangdong Medical College · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods and results: Therefore, we investigated the effect of DZ2002 on Discussion: In summary, our results indicated that DZ2002 may interact with SahH in PAO1, inhibiting the formation of mature biofilms by downregulating alginate synthesis, extracellular DNA production and swarming motility. These findings demonstrate the potential value of DZ2002 in treating biofilm infections associated with

Indexed as

ButyratesDNAPseudomonas aeruginosaAdenineAdenosylhomocysteinaseAlginatesBiofilmsMolecular Docking SimulationAdenineAdenosylhomocysteinaseAlginatesButyratesDNAmethyl 4-(adenin-9-yl)-2-hydroxybutanoatealginatebiofilmDZ2002extracellular DNAPseudomonas aeruginosa

Identifiers

PMID38268790
PMCPMC10806038
OpenAlexW4390698890

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.